Skip to content
In English |
En español
Search
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -3 of 3
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
6/11/2008
 
First Published:
7/14/2006
1.
Phase III Randomized Study of Soy Protein/Isoflavones and Venlafaxine on Vasomotor Symptoms in Patients With Prostate Cancer Undergoing Hormonal Manipulation
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Supportive care
Active
21 and over
NCI
CCCWFU-97405
CCCWFU 97405, CCCWFU-BG05-529, NCT00354432
Last Modified:
8/31/2005
 
First Published:
5/28/2004
2.
Randomized Study of Venlafaxine or Another Serotonin-Reuptake Inhibitor With Versus Without Zolpidem For Hot Flushes and Associated Sleep Problems in Women With Breast Cancer or at High Risk for Developing Breast Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
No phase specified
Supportive care
Active
18 to 65
Other
MGH-DFCI-02311
DFCI-02311, NCT00084669
Last Modified:
5/28/2008
 
First Published:
4/23/2008
3.
Study of the Pharmacokinetics of Tamoxifen Citrate in Women With or At High Risk For Developing Breast Cancer Who Are Receiving Selective Serotonin Reuptake Inhibitor/Serotonin-Norepinephrine Reuptake Inhibitor Therapy Comprising Venlafaxine, Citalopram Hydrobromide, Escitalopram Oxalate, Gabapentin, or Sertraline Hydrochloride for the Treatment of Hot Flashes, Depression, or Any Other Medically Indicated Condition
Phase
Type
Status
Age
Sponsor
Protocol IDs
No phase specified
Biomarker/Laboratory analysis, Treatment
Active
18 and over
NCI
MAYO-MC0738
MC0738, NCT00667121
Select All on One Page
NCI Home
|
Text-Only Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute